Qualidade de vida em adultos com Transtorno de Déficit de Atenção e Hiperatividade (TDAH) em uso do metilfenidato: revisão.

Abstract

Attention deficit hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized by a pattern of constant inattention and / or increased impulsivity or hyperactivity with functional interference in development. Current Medical Research indicates that adults are the fastest growing segment within the population diagnosed and treated with ADHA disorder. It is estimated that half of the children diagnosed with attention deficit hyperactivity disorder continue with harmful symptoms in adulthood. Evidence-based medicine shows that the targeted therapy of this disorder is its central pillar in drug treatment having as first-line drug stimulant of the central nervous system methylphenidate. The aim of this study is to evaluate the improvement in the quality of life of adults diagnosed with attention deficit hyperactivity disorder in use of methylphenidate compared to placebo or no drug treatment, based on the analysis of scientific studies. The method used in this work was the integrative review, on April 11, 2016, using the health descriptors: methylphenidate, adult, quality of life, adhd, in health data sources Pubmed, Lillacs, SciELO delimiting the inclusion criteria as the articles published in the years 2006-2015, in English, Portuguese and / or Spanish, with abstracts and full texts available in searchable databases, which made reference to the adult population and the title of the article would fit the proposed theme, whose method adopted was strong evidence. It was concluded from the current study is consistent evidence of effectiveness and safety in the use of methylphenidate and remarkable improvement in various parameters evaluated on the quality of life in adults diagnosed with attention deficit hyperactivity disorder in use of methylphenidate in adulthood.